Pfizer re-organises into three business units
Pfizer has announced a re-organisation of its operations into three distinct businesses.
Read More
Tag: innovative medicines
NICE OKs £20m budget impact limit for new drugs
The pharma industry and patient groups are warning of significant delays in accessing innovative medicines on the NHS after a new budget impact threshold was waved through by health officials.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
